New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 19, 2014
09:02 EDTRTIX, ZMHRTI Surgical unit signs agreement with Zimmer
RTI Surgical (RTIX) announced that the companyís wholly owned subsidiary, Pioneer Surgical Technology Surgical, has signed an agreement with Zimmer (ZMH) to supply integrated plates and cables, cannulated screws and instrumentation for Zimmerís trauma business. Under the agreement, the company will manufacture the metal products at its Marquette, MI facility for distribution by Zimmer Trauma.
News For RTIX;ZMH From The Last 14 Days
Check below for free stories on RTIX;ZMH the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 24, 2014
15:11 EDTZMHZimmer valuation not reflecting Biomet deal potential, says Cantor
Cantor says Zimmer remains its preferred name in orthopedics despite its "disappointing" Q2 report, as the firm believes the stock's valuation doesn't properly reflects the potential from its tie-up with Biomet. Cantor thinks Zimmer management's synergy targets are possibly conservative and raised its price target on the stock to $117 from $113.
08:27 EDTZMHZimmer 'confident' Biomet merger transaction to be completed in 1Q15
Subscribe for More Information
08:25 EDTZMHZimmer sees FY14 gross margin ratio at 73%-74%
Expects FY14 SG&A to be unchanged, although it says there will be a seasonally higher ratio in Q3. Sees FY14 tax rate of 25.5%.
08:25 EDTZMHZimmer sees Q3 EPS $1.29-$1.31, consensus $1.37
Subscribe for More Information
08:19 EDTZMHLeerink medical devices analyst holds an analyst/industry conference call
Subscribe for More Information
08:09 EDTRTIXRTI Surgical sees Q3 EPS 2c, consensus 2c
Subscribe for More Information
08:08 EDTRTIXRTI Surgical raises FY14 EPS ex-items 9c-11c from 7c-9c, consensus 8c
Subscribe for More Information
08:07 EDTRTIXRTI Surgical reports Q2 EPS 3c, consensus 2c
Reports Q2 revenue $66M, consensus $59.20M.
07:48 EDTZMHZimmer cuts FY14 EPS to $6.00-$6.10 from $6.00-$6.20, consensus $6.12
Subscribe for More Information
07:47 EDTZMHZimmer reports Q2 adjusted EPS $1.49, consensus $1.49
Reports Q2 revenue $1.18b, consensus $1.21B
July 22, 2014
08:15 EDTZMHZimmer should be bought on any weakness from Q2 results, says RBC Capital
RBC Capital believes that consensus Q2 recon estimates for Zimmer may be "a bit optimistic," but the firm thinks that investors already partially anticipate a miss on that metric The firm recommends buying the stock on any weakness associated with Q2 results, as it thinks the company's valuation is favorable, given its growth outlook. RBC Capital keeps a $120 price target and Outperform rating on the shares.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use